A prospective study to evaluate the impact of 31P-MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patients

Amyotrophic Lateral Sclerosis

Volumn 8, Issue 1, 2007, Pages 4-8

  Grehl, Torsten ^a   Fischer, Stephan ^c   Müller, Klaus ^b   Malin, Jean Pierre ^a   Zange, Jochen ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b GERMAN AEROSPACE CENTER DLR   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE DURATION; ENERGY METABOLISM; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; ISOMETRIC EXERCISE; MALE; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MUSCLE CONTRACTION; MUSCLE MITOCHONDRION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ENERGY METABOLISM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DISEASES; PHOSPHORUS ISOTOPES; PROSPECTIVE STUDIES;

EID: 33847309054     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960600765065     Document Type: Article

References (35)

1. Wong, P. C.,.Rothstein, J. D. and Price, D. L. (1998) The genetic and molecular mechanisms of motor neuron disease. Curr Opin Neurobiol, 8, pp. 791-799.
2. Rosen, D. R.,.Siddique, T.,.Patterson, D.,.Figlewicz, D. A.,.Sapp, P. and Hentati, A. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, pp. 59-62.
3. Wong, P. C.,.Pardo, C. A.,.Borchelt, D. R.,.Lee, M. K.,.Copeland, N. G. and Jenkins, N. A. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14, pp. 1105-1116.
4. Gonatas, N. K.,.Gonatas, J. O. and Stieber, A. (1998) The involvement of the Golgi apparatus in the pathogenesis of amyotrophic lateral sclerosis, Alzheimer's disease, and ricin intoxication. Histochem Cell Biol, 109, pp. 591-600.
5. Mourelatos, Z.,.Gonatas, N. K.,.Stieber, A.,.Gurney, M. E. and Canto, M. C. Dal (1996) The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu/Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA, 93, pp. 5472-5477.
6. Sasaki, S. and Iwata, M. (1996) Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett, 204, pp. 53-56.
7. Comi, G. P.,.Bordoni, A.,.Salani, S.,.Franceschina, L.,.Sciacco, M. and Prelle, A. (1998) Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol, 43, pp. 110-116.
8. Gabbianelli, R.,.Ferri, A.,.Rotilio, G. and Carri, M. T. (1999) Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis. J Neurochem, 73, pp. 1175-1180.
9. Richter, C. and Frei, B. (1988) Ca2+ release from mitochondria induced by pro-oxidants. Free Radic Biol Med, 4, pp. 365-375.
10. Zhang, Y.,.Marcillat, O.,.Giulivi, C.,.Ernster, L. and Davies, K. J. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem, 265, pp. 16330-16336.
11. Menzies, F. M.,.Ince, P. G. and Shaw, P. J. (2002) Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int, 40, pp. 543-551.
12. Gurney, M. E. (1994) Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med, 331, pp. 1721-1722.
13. Kong, J. and Xu, Z. (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci, 18, pp. 3241-3250.
14. Borthwick, G. M.,.Johnson, M. A.,.Ince, P. G.,.Shaw, P. J. and Turnbull, D. M. (1999) Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death. Ann Neurol, 46, pp. 787-790.
15. Kaal, E. C.,.Vlug, A. S.,.Versleijen, M. W.,.Kuilman, M.,.Joosten, E. A. and Bar, P. R. (2000) Chronic mitochondrial inhibition induces selective motor neuron death in vitro: A new model for amyotrophic lateral sclerosis. J Neurochem, 74, pp. 1158-1165.
16. Klivenyi, P.,.Ferrante, R. J.,.Matthews, R. T.,.Bogdanov, M. B.,.Klein, A. M. and Andreassen, O. A. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med, 5, pp. 347-350.
17. Nakano, Y.,.Hirayama, K. and Terao, K. (1987) Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol, 44, pp. 103-106.
18. Curti, D.,.Malaspina, A.,.Facchetti, G.,.Camana, C.,.Mazzini, L. and Tosca, P. (1996) Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology, 47, pp. 1060-1064.
19. Afifi, A. K.,.Aleu, F. P.,.Goodgold, J. and MacKay, B. (1966) Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis. Neurology, 16, pp. 475-481.
20. Vielhaber, S.,.Kunz, D.,.Winkler, K.,.Wiedemann, F. R.,.Kirches, E. and Feistner, H. (2000) Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain, 123, pp. 1339-1348.
21. Vielhaber, S.,.Winkler, K.,.Kirches, E.,.Kunz, D.,.Buchner, M. and Feistner, H. (1999) Visualization of defective mitochondrial function in skeletal muscle fibres of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci, 169, pp. 133-139.
22. Wiedemann, F. R.,.Winkler, K.,.Kuznetsov, A. V.,.Bartels, C.,.Vielhaber, S. and Feistner, H. (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci, 156, pp. 65-72.
23. Krasnianski, A.,.Deschauer, M.,.Neudecker, S.,.Gellerich, F. N.,.Muller, T. and Schoser, B. G. (2005) Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain, 128, pp. 1870-1876.
24. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease (1995) Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House 'Therapeutic Trials in ALS' Workshop Contributors. J Neurol Sci, 129
25. Vorgerd, M.,.Grehl, T.,.Jager, M.,.Müller, K.,.Freitag, G. and Patzold, T. (2000) Creatine therapy in myophosphorylase deficiency (McArdle disease): A placebo-controlled crossover trial. Arch Neurol, 57, pp. 956-963.
26. Vorgerd, M.,.Schöls, L.,.Hardt, C.,.Ristow, M.,.Epplen, J. T. and Zange, J. (2000) Mitochondrial impairment of human muscle in Friedreich ataxia in vivo. Neuromuscul Disord, 10, pp. 430-435.
27. Saft, C.,.Zange, J.,.Andrich, J.,.Müller, K.,.Lindenberg, K. and Landwehrmeyer, B. (2005) Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord, 20, pp. 674-679.
28. Andreassen, O. A.,.Ferrante, R. J.,.Klivenyi, P.,.Klein, A. M.,.Dedeoglu, A. and Albers, D. S. (2001) Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Exp Neurol, 168, pp. 356-363.
29. Bowling, A. C.,.Schulz, J. B.,.Brown, R. H Jr. and Beal, M. F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem, 61, pp. 2322-2325.
30. Wiedemann, F. R.,.Manfredi, G.,.Mawrin, C.,.Beal, M. F. and Schon, E. A. (2002) Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem, 80, pp. 616-625.
31. Echaniz-Laguna, A.,.Zoll, J.,.Ribera, F.,.Tranchant, C.,.Warter, J. M. and Lonsdorfer, J. (2002) Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol, 52, pp. 623-627.
32. Leclerc, N.,.Ribera, F.,.Zoll, J.,.Warter, J. M.,.Poindron, P. and Lampert, E. (2001) Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibres isolated from G93A human SOD1 transgenic mice. Neuromuscul Disord, 11, pp. 722-727.
33. Siciliano, G.,.Pastorini, E.,.Pasquali, L.,.Manca, M. L.,.Iudice, A. and Murri, L. (2001) Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci, 191, pp. 61-65.
34. Beal, M. F. (2000) Mitochondria and the pathogenesis of ALS. Brain, 123, pp. 1291-1292.
35. Radda, G. K.,.Bore, P. J.,.Gadian, D. G.,.Ross, B. D.,.Styles, P. and Taylor, D. J. (1982) 31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature, 295, pp. 608-609.